An Open-Label, Single-Dose, Multicenter, Pharmacokinetic, Safety and Tolerability Study of Valaciclovir Oral Suspension in Infants and Children
Phase of Trial: Phase I
Latest Information Update: 13 Sep 2017
At a glance
- Drugs Valaciclovir (Primary)
- Indications Herpes simplex virus infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 24 Jan 2011 Additional locations (Argentina, Sweden) identified as reported by ClinicalTrials.gov.
- 15 Oct 2008 Actual start date changed from Dec 2002 to Jan 2003 as reported by ClinicalTrials.gov.
- 09 Jun 2008 Status changed from in progress to completed according to ClinicalTrials.gov.